Fewer than 50 people in recorded medical history have been confirmed to carry “golden blood,” the colloquial name for the Rhnull phenotype, a blood type that completely lacks every antigen in the Rh blood group system. A 2018 review counted at least 43 individuals from 14 families worldwide, and only a handful of those are active blood donors at any given time.1PubMed Central. First Report of Known Rare Rhnull Phenotype Individuals in Iran The rarity comes down to genetics: two separate copies of a faulty gene must line up in the same person, an event so unlikely it surfaces mostly in families where close relatives marry. But the story behind golden blood goes well beyond a number, because the same proteins it lacks turn out to be surprisingly important to how red blood cells hold together and move gases through the body.
What the Rh System Actually Does on a Red Blood Cell
Most people know about “Rh positive” and “Rh negative” from blood-type cards, but that plus-or-minus label refers to just one of more than 50 antigens in the full Rh group. The proteins carrying those antigens sit embedded in the red blood cell membrane, and they do more than just wave molecular flags at the immune system. Together with a partner protein called RhAG, the Rh proteins anchor into the cell’s internal skeleton, helping maintain the red blood cell’s distinctive flexible disc shape.2Blood Reviews. Rh proteins: Key structural and functional components of the red cell membrane They also form channels that shuttle ammonia and carbon dioxide across the membrane.3PubMed Central. The structure and function of the Rh antigen complex
Lab measurements show this gas-channel role is substantial. Red blood cells from Rhnull individuals let carbon dioxide through at roughly half the rate of normal cells, dropping from about 0.15 cm/s to around 0.07 cm/s.4PubMed. RhAG protein of the Rhesus complex is a CO2 channel in the human red cell membrane That reduction is large enough to matter physiologically, because red blood cells need to pick up COâ‚‚ in the tissues and dump it in the lungs within a fraction of a second. When that process slows, the cells work less efficiently as gas couriers.
Two Genetic Roads to Zero Rh Antigens
Golden blood arises through one of two distinct genetic mechanisms. The more common path is the “regulator type,” where the genes encoding the Rh antigens themselves are perfectly normal, but mutations in the RHAG gene knock out the partner protein that ferries those antigens to the cell surface. Without RhAG acting as an escort, the Rh proteins never reach the membrane.5International Immunopharmacology. Double heterozygous RhAG mutations causing regulator-type Rhnull phenotype The second path, the “amorph type,” involves mutations directly in the RHD and RHCE genes that encode the antigens, so there is simply nothing to deliver in the first place.5International Immunopharmacology. Double heterozygous RhAG mutations causing regulator-type Rhnull phenotype
In the regulator type, even a single working copy of RHAG is enough to get some Rh antigens onto the cell surface, which means a person needs two broken copies to reach the Rhnull state. Genetic studies of regulator-type individuals have turned up a range of different RHAG mutations, including single-letter changes deep inside the gene that wreck the protein’s ability to sit properly in the membrane. One well-characterized donor, for example, carried two different mutations on the two copies of the gene, with one copy silenced entirely so that only the mutant version produced any protein at all.6Blood. A Novel Single Missense Mutation Identified Along the RH50 Gene in a Composite Heterozygous Rhnull Blood Donor of the Regulator Type
Why Golden Blood Is So Extraordinarily Rare
Both paths to Rhnull are autosomal recessive, meaning you need to inherit a broken copy from each parent. In most populations, the carrier frequency for these mutations is vanishingly small. The chance that two carriers meet, marry, and have a child who inherits both copies is astronomically low in outbred populations. This is why the confirmed cases cluster in families with consanguineous (closely related) parents, where the odds of both parents carrying the same rare mutation rise sharply.
Even within those families, only one in four children on average will be Rhnull. The rest will either be carriers who show no outward signs or will have completely normal Rh expression. And because the condition has no dramatic outward symptoms that send people to a doctor, many Rhnull individuals probably go their entire lives without being identified. The only reliable way to discover the phenotype is through blood typing that specifically tests for Rh antigens, which standard screening panels sometimes skip beyond the basic D antigen. The true number of people with golden blood worldwide could be somewhat higher than the documented 43, but it is almost certainly still measured in the dozens or very low hundreds.
Living with Rhnull Red Blood Cells
Golden blood is not just a curiosity of blood banking; it comes with genuine physiological consequences. Without the Rh protein complex stabilizing their membranes, Rhnull red blood cells are abnormally shaped and fragile. They show irregularities in their disc shape, problems with how ions pass through the membrane, and a disordered arrangement of the lipids that make up the membrane itself.7ScienceDirect. RH blood group system and molecular basis of Rh-deficiency Clinically, this translates into a mild but chronic hemolytic anemia in many Rhnull individuals. Their red blood cells break down faster than normal, which the body partially compensates for by producing more, but the balance is imperfect enough to cause slightly low hemoglobin levels in some people.
The severity varies. Some individuals are entirely asymptomatic and only learn about their blood type when they donate blood or get typed for surgery. Others experience fatigue or mild jaundice from the ongoing low-grade destruction of red cells. The condition is not life-threatening on its own, but it does make every interaction with the medical system more complicated, because the real danger of golden blood lies not in what it does inside the body but in what happens when someone with it needs blood from outside.
The Transfusion Dilemma
A person with Rhnull blood can receive only Rhnull blood. Any red cells carrying Rh antigens, no matter how common the donor’s blood type might be, will look foreign to the Rhnull recipient’s immune system. If an Rhnull individual is ever exposed to Rh-positive blood, whether through a transfusion or a pregnancy, they can develop a powerful antibody called anti-Rh29 that reacts against every Rh antigen.8PubMed. Rh(null) phenotype: molecular basis, serologic features, clinical manifestations, and transfusion challenges-a scoping review of published cases Once that antibody is present, the person’s body will attack and destroy any transfused cells that carry Rh markers, making virtually all donated blood in the world incompatible.
This creates a brutal logistical problem. With only a handful of active Rhnull donors anywhere on the planet, finding compatible blood in an emergency can be nearly impossible. Some Rhnull individuals bank their own blood (autologous donation) ahead of planned surgeries, and family members who share the phenotype sometimes serve as directed donors. Frozen rare-blood inventories maintained by national blood services offer another lifeline, though keeping enough units frozen and within their shelf life for a population scattered across continents is a constant challenge.
The paradox is that Rhnull blood is simultaneously the rarest and the most universally compatible within the Rh system. Because it carries no Rh antigens at all, it can theoretically be given to anyone with Rh antibodies who cannot receive conventional Rh-positive or Rh-negative blood. This makes golden blood extraordinarily valuable for patients with complex Rh antibody profiles, which is part of how it earned its nickname. But that universal-donor quality only deepens the ethical tension: every unit of Rhnull blood donated to help someone else is a unit the donor themselves may desperately need someday.
How Rare Donor Registries Try to Close the Gap
Because no single hospital or blood bank can maintain a supply of golden blood, international networks have been built to track the handful of known Rhnull donors and connect them with patients in need. The American Rare Donor Program, established in 1998, maintains a database called REGGI that logs the phenotypes of rare donors alongside the antibody profiles of patients searching for compatible blood. When a match is found, the system coordinates unit procurement and shipment.9PubMed Central. REGGI and the American Rare Donor Program
At the international level, the International Society of Blood Transfusion oversees a Working Party on Rare Donors that encourages countries to submit their rare donors’ phenotype and genotype data to a centralized catalog, the WHO International Rare Donor Panel.10PubMed. International rare donor panels: a review These registries work, but they depend entirely on voluntary participation by donors who are scattered around the globe, often in different countries with different regulatory systems governing blood export. Shipping frozen red cells across borders involves cold-chain logistics, customs clearance, and time that a patient hemorrhaging on an operating table does not have.
The reality is that these registries are more of a safety net than a reliable pipeline. They work best for planned procedures where there is time to search the database and coordinate a shipment. For trauma or emergency surgery, Rhnull patients and their physicians are largely on their own, relying on autologous reserves if they exist or, in the worst case, accepting incompatible blood and managing the immune reaction as best they can.
Pregnancy and Golden Blood
Pregnancy adds an entirely separate layer of risk for women with Rhnull blood. During pregnancy, fetal red blood cells routinely cross into the mother’s circulation. If the fetus has inherited normal Rh antigens from the father, the mother’s immune system will recognize those antigens as foreign and can mount a powerful antibody response. In subsequent pregnancies, those antibodies can cross the placenta and attack the fetus’s red cells, causing hemolytic disease of the fetus and newborn.
A recent structured review of published Rhnull pregnancies found that outcomes ranged from mild neonatal hemolysis to severe fetal or neonatal disease. One case required an intrauterine transfusion because the fetus became severely anemic before delivery, and another newborn needed repeated exchange transfusions to survive.11PubMed. Managing pregnancy in women with the Rh-null phenotype: A structured narrative review of alloimmunisation, maternal-fetal outcomes and transfusion management In one particularly well-documented Brazilian case, a 35-year-old Rhnull woman delivered a severely anemic infant whose cord blood showed extremely high antibody titers against cells of every normal Rh phenotype. The baby required two exchange transfusions within 24 hours of birth.12Vox Sanguinis. Severe Haemolytic Disease in an Infant Born to an Rh(null) Proposita
Exchange transfusions for these newborns are themselves logistically fraught, because ideally the replacement blood should be Rhnull to avoid further immune stimulation. In practice, clinicians sometimes resort to blood that is at least partially Rh-depleted, or they use standard Rh-negative blood and accept a degree of immune incompatibility. Pregnancy planning and close monitoring with a maternal-fetal medicine specialist are strongly recommended for any Rhnull woman considering having children, but for women in resource-limited settings who may not even know their blood type, this level of care is not always available.
How Golden Blood Gets Identified
Standard blood typing at a hospital or blood bank tests for the ABO group and the D antigen (the plus or minus in your blood type). That simple screen will never catch Rhnull on its own, because Rhnull individuals type as Rh-negative by default, since they lack D along with everything else. The phenotype typically surfaces only when extended antigen panels are run, often because something unexpected happens during a crossmatch before a transfusion. A technician notices that the patient’s serum reacts with an unusually broad range of donor cells, which triggers further testing.
Confirming the phenotype requires serological testing against a panel of antibodies that detect specific Rh antigens like C, c, E, and e, plus molecular analysis to identify the underlying gene mutations. Flow cytometry can quantify the amount of RhAG protein on the cell surface, helping distinguish between completely absent expression and the merely reduced levels seen in some partial-deletion phenotypes.13Transfusion. The 2 breakpoint regions of an RHCE-D(2-9)-CE allele causing a D– phenotype DNA sequencing then pinpoints whether the individual has the regulator type, the amorph type, or one of the rarer hybrid gene rearrangements that can also wipe out Rh expression.
This multi-step diagnostic pathway is one reason Rhnull goes underdiagnosed. In populations where extended antigen typing is not routine, carriers and even homozygous Rhnull individuals slip through the system. Expanded use of molecular blood-group genotyping in blood banks worldwide would likely uncover a few more cases, though the number would still remain extremely small.
Gene Editing and the Prospect of a Manufactured Supply
The chronic shortage of golden blood has prompted researchers to explore whether compatible red cells could be manufactured rather than donated. One recent approach used CRISPR gene editing to modify stem cells derived from an Rhnull donor. The original donor had blood type A, so the researchers knocked out the ABO gene to convert the cells to type O, creating a stem cell line that could theoretically produce red blood cells carrying no Rh antigens and no A or B antigens, making them compatible with almost anyone.14PubMed Central. ABO gene editing for the conversion of blood type A to universal type O in Rhnull donor-derived human-induced pluripotent stem cells
The work is still in early stages. Growing red blood cells from stem cells in the lab is technically possible but remains expensive and difficult to scale. Current protocols can produce enough cells for research but not yet for routine transfusions. If the technology matures, though, it could eventually solve the golden-blood supply problem by turning a single donation of Rhnull cells into a renewable cell line capable of producing transfusion-grade blood indefinitely. The same principle could be extended to other rare blood phenotypes, where the mismatch between tiny donor pools and patient need creates similar emergencies.
For now, the handful of people with golden blood worldwide remain in an uneasy balance: extraordinarily valuable to medicine precisely because of the trait that makes their own medical care so precarious. They donate when they can, bank blood for themselves when possible, and hope that the rare-donor registries and frozen inventories will be enough if the day ever comes when they need blood that almost no one else on Earth can give them.